NIST Awards $153 M to NIIMBL

Posted August 9, 2021 by Carolyn Bloch

The National Institute of Standards and Technology (NIST), has awarded $153 million to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership ready to accelerate innovation in the biopharmaceutical industry. The U.S. biopharmaceutical industry produces vaccines, monoclonal antibodies, gene therapies, and other medical products derived from biological sources. The []

Read a full article at

Edit this page on GitHub